Supernus Pharmaceuticals, Inc. (SUPN)
45.11
-0.74
(-1.61%)
USD |
NASDAQ |
Aug 24, 16:00
45.11
0.00 (0.00%)
After-Hours: 20:00
Supernus Pharmaceuticals 1 Year Total Returns (Daily) : 5.84% for Aug. 21, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 21, 2026 | 5.84% |
| August 20, 2026 | 11.18% |
| August 19, 2026 | 15.57% |
| August 18, 2026 | 14.05% |
| August 17, 2026 | 13.07% |
| August 14, 2026 | 14.47% |
| August 13, 2026 | 10.58% |
| August 12, 2026 | 16.08% |
| August 11, 2026 | 15.55% |
| August 10, 2026 | 14.16% |
| August 07, 2026 | 14.91% |
| August 06, 2026 | 10.18% |
| August 05, 2026 | 24.99% |
| August 04, 2026 | 16.73% |
| August 03, 2026 | 29.56% |
| July 31, 2026 | 27.15% |
| July 30, 2026 | 35.91% |
| July 29, 2026 | 39.22% |
| July 28, 2026 | 42.86% |
| July 27, 2026 | 39.90% |
| July 24, 2026 | 40.64% |
| July 23, 2026 | 43.13% |
| July 22, 2026 | 43.68% |
| July 21, 2026 | 44.06% |
| July 20, 2026 | 46.63% |
| Date | Value |
|---|---|
| July 17, 2026 | 43.02% |
| July 16, 2026 | 43.82% |
| July 15, 2026 | 42.44% |
| July 14, 2026 | 37.40% |
| July 13, 2026 | 42.96% |
| July 10, 2026 | 46.23% |
| July 09, 2026 | 49.22% |
| July 08, 2026 | 57.18% |
| July 07, 2026 | 52.43% |
| July 06, 2026 | 47.72% |
| July 02, 2026 | 49.83% |
| July 01, 2026 | 48.99% |
| June 30, 2026 | 47.56% |
| June 29, 2026 | 50.19% |
| June 26, 2026 | 50.13% |
| June 25, 2026 | 43.25% |
| June 24, 2026 | 42.53% |
| June 23, 2026 | 39.04% |
| June 22, 2026 | 37.79% |
| June 18, 2026 | 34.65% |
| June 17, 2026 | 34.82% |
| June 16, 2026 | 34.22% |
| June 15, 2026 | 36.93% |
| June 12, 2026 | 35.52% |
| June 11, 2026 | 37.41% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Indivior Pharmaceuticals, Inc. | 53.31% |
| Pfizer Inc. | 16.73% |
| Amphastar Pharmaceuticals, Inc. | -27.17% |
| Collegium Pharmaceutical, Inc. | -31.40% |
| Bristol Myers Squibb Co. | 44.96% |